Promotion of liver growth by CAR is accompanied by Akt pathway activation and FoxM1-Nedd4-mediated repression of PTEN

Standard

Promotion of liver growth by CAR is accompanied by Akt pathway activation and FoxM1-Nedd4-mediated repression of PTEN. / Yarushkin, Andrei A.; Mazin, Mark E.; Pustylnyak, Yuliya A. et al.

In: Archives of Biochemistry and Biophysics, Vol. 672, 108065, 15.09.2019, p. 108065.

Research output: Contribution to journal › Article › peer-review

BibTeX

@article{2df8bf4e631e4c94ac45158338ca0bb5,

title = "Promotion of liver growth by CAR is accompanied by Akt pathway activation and FoxM1-Nedd4-mediated repression of PTEN",

abstract = "Recently, we reported that treatment with the mouse agonist of the constitutive androstane receptor (CAR), 1,4-bis benzene[2-(3,5-dichloropyridyloxy)] (TCPOBOP; a well-known hepatomitogen), reduced PTEN protein levels, leading to Akt activation. Hence, the present study was performed to demonstrate the role of CAR in PTEN regulation and liver growth. Liver hyperplasia caused by CAR activation was confirmed to be mediated by a decrease in PTEN protein level and the activation of the Akt signalling pathway in the liver of mice. Treatment with the CAR agonist decreased the PTEN levels and increased Foxm1 levels, which correlate with the elevated expression of the FoxM1 target gene, Nedd4-1, an E3 ligase involved in PTEN ubiquitination, and the promotion of degradation. The increase in Nedd4-1 levels was accompanied by an increase in CAR-mediated accumulation of Foxm1 on the Nedd4-1 gene promoter. Therefore, these results provide evidence that a notable function of CAR is its liver growth promotion effect, which is accompanied by FoxM1-Nedd4-mediated repression of PTEN and Akt pathway activation.",

keywords = "Akt, Constitutive androstane receptor, FoxM1, Liver, Nedd4-1, PTEN, NEDD4-1, UBIQUITIN LIGASE, HEPATECTOMY, REGENERATION, CELL-SURVIVAL, NUCLEAR RECEPTOR, INHIBITION, CONSTITUTIVE ANDROSTANE RECEPTOR, TUMOR-SUPPRESSOR, EXPRESSION",

author = "Yarushkin, {Andrei A.} and Mazin, {Mark E.} and Pustylnyak, {Yuliya A.} and Prokopyeva, {Elena A.} and Pustylnyak, {Vladimir O.}",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2019",

month = sep,

day = "15",

doi = "10.1016/j.abb.2019.108065",

language = "English",

volume = "672",

pages = "108065",

journal = "Archives of Biochemistry and Biophysics",

issn = "0003-9861",

publisher = "Academic Press Inc.",

}

RIS

TY - JOUR

T1 - Promotion of liver growth by CAR is accompanied by Akt pathway activation and FoxM1-Nedd4-mediated repression of PTEN

AU - Yarushkin, Andrei A.

AU - Mazin, Mark E.

AU - Pustylnyak, Yuliya A.

AU - Prokopyeva, Elena A.

AU - Pustylnyak, Vladimir O.

PY - 2019/9/15

Y1 - 2019/9/15

N2 - Recently, we reported that treatment with the mouse agonist of the constitutive androstane receptor (CAR), 1,4-bis benzene[2-(3,5-dichloropyridyloxy)] (TCPOBOP; a well-known hepatomitogen), reduced PTEN protein levels, leading to Akt activation. Hence, the present study was performed to demonstrate the role of CAR in PTEN regulation and liver growth. Liver hyperplasia caused by CAR activation was confirmed to be mediated by a decrease in PTEN protein level and the activation of the Akt signalling pathway in the liver of mice. Treatment with the CAR agonist decreased the PTEN levels and increased Foxm1 levels, which correlate with the elevated expression of the FoxM1 target gene, Nedd4-1, an E3 ligase involved in PTEN ubiquitination, and the promotion of degradation. The increase in Nedd4-1 levels was accompanied by an increase in CAR-mediated accumulation of Foxm1 on the Nedd4-1 gene promoter. Therefore, these results provide evidence that a notable function of CAR is its liver growth promotion effect, which is accompanied by FoxM1-Nedd4-mediated repression of PTEN and Akt pathway activation.

AB - Recently, we reported that treatment with the mouse agonist of the constitutive androstane receptor (CAR), 1,4-bis benzene[2-(3,5-dichloropyridyloxy)] (TCPOBOP; a well-known hepatomitogen), reduced PTEN protein levels, leading to Akt activation. Hence, the present study was performed to demonstrate the role of CAR in PTEN regulation and liver growth. Liver hyperplasia caused by CAR activation was confirmed to be mediated by a decrease in PTEN protein level and the activation of the Akt signalling pathway in the liver of mice. Treatment with the CAR agonist decreased the PTEN levels and increased Foxm1 levels, which correlate with the elevated expression of the FoxM1 target gene, Nedd4-1, an E3 ligase involved in PTEN ubiquitination, and the promotion of degradation. The increase in Nedd4-1 levels was accompanied by an increase in CAR-mediated accumulation of Foxm1 on the Nedd4-1 gene promoter. Therefore, these results provide evidence that a notable function of CAR is its liver growth promotion effect, which is accompanied by FoxM1-Nedd4-mediated repression of PTEN and Akt pathway activation.

KW - Akt

KW - Constitutive androstane receptor

KW - FoxM1

KW - Liver

KW - Nedd4-1

KW - PTEN

KW - NEDD4-1

KW - UBIQUITIN LIGASE

KW - HEPATECTOMY

KW - REGENERATION

KW - CELL-SURVIVAL

KW - NUCLEAR RECEPTOR

KW - INHIBITION

KW - CONSTITUTIVE ANDROSTANE RECEPTOR

KW - TUMOR-SUPPRESSOR

KW - EXPRESSION

UR - http://www.scopus.com/inward/record.url?scp=85071788077&partnerID=8YFLogxK

U2 - 10.1016/j.abb.2019.108065

DO - 10.1016/j.abb.2019.108065

M3 - Article

C2 - 31394088

AN - SCOPUS:85071788077

VL - 672

SP - 108065

JO - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

M1 - 108065

ER -

ID: 21466307